Journal of Pharmaceutical Analysis
https://jpa.xjtu.edu.cn/
Journal of Pharmaceutical Analysisjpaeditor@xjtu.edu.cnjpaeditor@xjtu.edu.cnenjpaeditor@xjtu.edu.cn2095-1779<![CDATA[Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101382?pageType=en
2025-07-01Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101382-.articledoi:10.1016/j.jpha.2025.10138210.1016/j.jpha.2025.101382Journal of Pharmaceutical Analysis1632025-07-01https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101382?pageType=en101382<![CDATA[Antimicrobial sonodynamic therapy: Recent advances and challenges in new therapeutic approaches to antimicrobials]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101375?pageType=en
2025-06-23Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101375-.articledoi:10.1016/j.jpha.2025.10137510.1016/j.jpha.2025.101375Journal of Pharmaceutical Analysis1632025-06-23https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101375?pageType=en101375<![CDATA[A comprehensive narrative review of <i>Epimedium</i> and its bioactive compounds in respiratory diseases]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101374?pageType=en
2025-06-20Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101374-.articledoi:10.1016/j.jpha.2025.10137410.1016/j.jpha.2025.101374Journal of Pharmaceutical Analysis1632025-06-20https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101374?pageType=en101374<![CDATA[Exploring TGFBR3 in disease pathogenesis: Mechanisms, clinical implications, and pharmacological modulation]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101372?pageType=en
2025-06-19Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101372-.articledoi:10.1016/j.jpha.2025.10137210.1016/j.jpha.2025.101372Journal of Pharmaceutical Analysis1632025-06-19https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101372?pageType=en101372<![CDATA[Mechanisms and therapeutic potential of YTHDF readers: Linking epitranscriptomics to cancer]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101371?pageType=en
2025-06-19Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101371-.articledoi:10.1016/j.jpha.2025.10137110.1016/j.jpha.2025.101371Journal of Pharmaceutical Analysis1632025-06-19https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101371?pageType=en101371<![CDATA[Astrocytes: Unveiling their role in the molecular mechanism of natural antidepressants]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101370?pageType=en
2025-06-20Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101370-.articledoi:10.1016/j.jpha.2025.10137010.1016/j.jpha.2025.101370Journal of Pharmaceutical Analysis1632025-06-20https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101370?pageType=en101370<![CDATA[Phytomedicine-mediated time-dependent inactivation of CYP3A4 by chemical modification]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101352?pageType=en
2025-05-26Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101352-.articledoi:10.1016/j.jpha.2025.10135210.1016/j.jpha.2025.101352Journal of Pharmaceutical Analysis1632025-05-26https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101352?pageType=en101352<![CDATA[The correlation between characteristics and pharmacological effects of monoterpene glycosides and tannins in Radix Paeoniae Alba]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101471?pageType=en
2025-10-25Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101471-.articledoi:10.1016/j.jpha.2025.10147110.1016/j.jpha.2025.101471Journal of Pharmaceutical Analysis1632025-10-25https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101471?pageType=en101471<![CDATA[Recent advances in the analysis of unsaturated fatty acids in biological samples based on chemical derivatization and mass spectrometry techniques]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101491?pageType=en
2025-11-06Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101491-.articledoi:10.1016/j.jpha.2025.10149110.1016/j.jpha.2025.101491Journal of Pharmaceutical Analysis1632025-11-06https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101491?pageType=en101491<![CDATA[Development and validation of a static multiple light scattering (SMLS) method for real-time colloidal stability assessment in nanoparticle formulations]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101396?pageType=en
2025-07-05Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101396-.articledoi:10.1016/j.jpha.2025.10139610.1016/j.jpha.2025.101396Journal of Pharmaceutical Analysis1632025-07-05https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101396?pageType=en101396<![CDATA[Metabolic heterogeneity, networks, and biomarkers of drug-induced liver injury]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101496?pageType=en
2025-11-13Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101496-.articledoi:10.1016/j.jpha.2025.10149610.1016/j.jpha.2025.101496Journal of Pharmaceutical Analysis1632025-11-13https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101496?pageType=en101496<![CDATA[Apatinib and silver nanoparticles synergize against gastric cancer through the PI3K/Akt signaling pathway-mediated ferroptosis]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101400?pageType=en
2025-07-12Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101400-.articledoi:10.1016/j.jpha.2025.10140010.1016/j.jpha.2025.101400Journal of Pharmaceutical Analysis1632025-07-12https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101400?pageType=en101400<![CDATA[Dual regulation of antiviral IFN response by <i>Scutellariae Radix</i>: Therapeutic implications for influenza]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101399?pageType=en
2025-07-09Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101399-.articledoi:10.1016/j.jpha.2025.10139910.1016/j.jpha.2025.101399Journal of Pharmaceutical Analysis1632025-07-09https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101399?pageType=en101399<![CDATA[Equivariant graph neural network-based accurate and ultra-fast virtual screening of small molecules targeting miRNA-protein complex]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101339?pageType=en
2025-05-15Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101339-.articledoi:10.1016/j.jpha.2025.10133910.1016/j.jpha.2025.101339Journal of Pharmaceutical Analysis1632025-05-15https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101339?pageType=en101339<![CDATA[A novel proteolysis-targeting chimera strategy targeting multiple immune checkpoints containing ITIMs enhances antitumor immunity]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101511?pageType=en
2025-12-11Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101511-.articledoi:10.1016/j.jpha.2025.10151110.1016/j.jpha.2025.101511Journal of Pharmaceutical Analysis1632025-12-11https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101511?pageType=en101511<![CDATA[Rational design of a novel specific fluorescent substrate for monitoring hUGT1A4 activity and its application in identification of selective inhibitors]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101415?pageType=en
2025-07-26Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101415-.articledoi:10.1016/j.jpha.2025.10141510.1016/j.jpha.2025.101415Journal of Pharmaceutical Analysis1632025-07-26https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101415?pageType=en101415<![CDATA[MST4 as a key driver of osteoclast activation in osteoporosis]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101401?pageType=en
2025-07-09Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101401-.articledoi:10.1016/j.jpha.2025.10140110.1016/j.jpha.2025.101401Journal of Pharmaceutical Analysis1632025-07-09https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101401?pageType=en101401<![CDATA[Covalent modification of Keap1 Cys489 by NU6300 activates Nrf2 signaling and suppresses NLRP3 inflammasome-mediated pyroptosis]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101458?pageType=en
2025-09-30Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101458-.articledoi:10.1016/j.jpha.2025.10145810.1016/j.jpha.2025.101458Journal of Pharmaceutical Analysis1632025-09-30https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101458?pageType=en101458<![CDATA[Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101453?pageType=en
2025-09-18Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101453-.articledoi:10.1016/j.jpha.2025.10145310.1016/j.jpha.2025.101453Journal of Pharmaceutical Analysis1632025-09-18https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101453?pageType=en101453<![CDATA[Crebanine protects against ovariectomy-induced bone loss by targeting Sirt1 to interfere with NF-κB acetylation and ROS activity]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101426?pageType=en
2025-07-31Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101426-.articledoi:10.1016/j.jpha.2025.10142610.1016/j.jpha.2025.101426Journal of Pharmaceutical Analysis1632025-07-31https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101426?pageType=en101426<![CDATA[An ultrasensitive and rapid immunoassay for the analysis of <i>Helicobacter pylori</i> in clinical samples based on hollow gold nanoparticles]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101425?pageType=en
2025-07-30Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101425-.articledoi:10.1016/j.jpha.2025.10142510.1016/j.jpha.2025.101425Journal of Pharmaceutical Analysis1632025-07-30https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101425?pageType=en101425<![CDATA[Feature-based molecular networking and building blocks identification advance novel natural products characterization: Sesquiterpene-chromone hybrids in agarwood as an application]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101478?pageType=en
2025-10-30Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101478-.articledoi:10.1016/j.jpha.2025.10147810.1016/j.jpha.2025.101478Journal of Pharmaceutical Analysis1632025-10-30https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2025.101478?pageType=en101478<![CDATA[Corrigendum to “ACtriplet: An improved deep learning model for activity cliffs prediction by integrating triplet loss and pre-training” [J. Pharm. Anal., 15 (2025) 101317]]]>
https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2026.101604?pageType=en
2026-03-20Personal use only, all commercial or other reuse prohibitedJournal of Pharmaceutical Analysis. 2026 16(3): 101604-.articledoi:10.1016/j.jpha.2026.10160410.1016/j.jpha.2026.101604Journal of Pharmaceutical Analysis1632026-03-20https://jpa.xjtu.edu.cn/article/doi/10.1016/j.jpha.2026.101604?pageType=en101604